Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,475,409 papers from all fields of science
Search
Sign In
Create Free Account
ADPRH gene
Known as:
ADP-ribosylarginine hydrolase
, ADPRH
, ARH1
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Metabolic response to Parkinson’s disease recapitulated by the haploinsufficient phenotype of diploid yeast cells hemizygous for the adrenodoxin reductase gene
Duygu Dikicioglu
,
J. Coxon
,
S. Oliver
bioRxiv
2019
Corpus ID: 181324078
Adrenodoxin reductase, a widely conserved mitochondrial P450 protein, catalyses essential steps in steroid hormone biosynthesis…
Expand
2019
2019
Metabolic response to Parkinson's disease recapitulated by the haploinsufficient diploid yeast cells hemizygous for the adrenodoxin reductase gene.
Duygu Dikicioglu
,
J. Coxon
,
S. Oliver
Molecular Omics
2019
Corpus ID: 201099087
Adrenodoxin reductase, a widely conserved mitochondrial P450 protein, catalyses essential steps in steroid hormone biosynthesis…
Expand
2011
2011
O-Acetyl-ADP-ribose Isomers as Substrates for ARH
A. Kasamatsu
,
Motoyuki Nakao
,
+5 authors
J. Moss
2011
Corpus ID: 9812313
O-Acetyl-ADP-ribose (OAADPr), produced by the Sir2-catalyzed NAD -dependent histone/protein deacetylase reaction, regulates…
Expand
2009
2009
Effects of ADP‐ribosylarginine Hydrolase (ARH1) on Cell Proliferation and Tumorigenesis
J. Kato
,
Jainfeng Zhu
,
+4 authors
J. Moss
2009
Corpus ID: 82107876
Mono‐ADP‐ribosylation, a post‐translational modification involving the transfer of ADP‐ribose from NAD to an acceptor protein is…
Expand
1995
1995
Differential binding activity of ARH1/TAM motifs.
J. Cambier
,
S. Johnson
Immunology Letters
1995
Corpus ID: 3424842
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE